Autres langues General Biologicals Corporation

Actions

4117

TW0004117007

Cours en clôture Taipei Exchange Autres places de cotation 00:00:00 13/05/2024			Varia. 5j.	Varia. 1 janv.
19,65 ^TWD	-0,76%		-2,72%	-27,22%

30/04	General Biologicals Corporation annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	General Biologicals Corporation annonce ses résultats pour le semestre clos le 30 juin 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	14/08/23
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2022	12/08/22
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	27/04/22
General Biologicals Corporation(TPEX:4117) dropped from S&P Global BMI Index	20/09/21
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2021	12/08/21
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	29/04/21
General Biologicals Corporation completed the acquisition of additional 77% stake in Pacgen Life Science Corporation.	30/09/20
General Biologicals Corporation(TPEX:4117) added to S&P Global BMI Index	21/09/20
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2020	13/08/20
General Biologicals Corporation announced that it has received TWD 77.623729 million in funding from Hong Kong Chlitina International Limited	23/07/20
General Biologicals Corporation entered into a letter of intent to acquire additional 77% stake in Pacgen Life Science Corporation for CAD 1.4 million.	07/07/20
General Biologicals Corporation Announces Develops Covid-19 Testing Solutions for Antigen and Antibody Detection	06/07/20
Savior Lifetec : Taiwanese companies fill US demand for medical supplies amid pandemic	09/06/20
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	28/04/20
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2019	13/08/19
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2018	29/04/19
General Biologicals Corporation Adds New Markets for P113 Products Licensed from Pacgen	24/01/17
GBC Introduces its New Discovery Line of Document Cameras	07/11/16

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues General Biologicals Corporation

Actions

4117

TW0004117007

Autres langues

Filtres